Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C63H111N11O12 |
Molecular Weight | 1214.6219 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
InChI
InChIKey=BICRTLVBTLFLRD-PTWUADNWSA-N
InChI=1S/C63H111N11O12/c1-25-27-28-29-41(15)53(76)52-57(80)66-44(26-2)59(82)68(18)34-49(75)69(19)45(30-35(3)4)56(79)67-50(39(11)12)62(85)70(20)46(31-36(5)6)55(78)64-42(16)54(77)65-43(17)58(81)71(21)47(32-37(7)8)60(83)72(22)48(33-38(9)10)61(84)73(23)51(40(13)14)63(86)74(52)24/h25,27-28,35-48,50-53,76H,1,26,29-34H2,2-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/b28-27+/t41-,42+,43-,44+,45+,46+,47+,48+,50+,51+,52+,53-/m1/s1
Voclosporin (trans-ISA247) is a Cyclosporin A derivative and immunosuppressive compound currently being investigated for the treatment of psoriasis, lupus nephritis and for the prevention of organ rejection in kidney transplant patients. An animal study showed that a lower blood level of Voclosporin was able to produce a greater or similar inhibition of lymphocyte proliferation, expression of T-cell activation surface antigens, and T-cell cytokine production compared to Cyclosporin A. Voclosporin has been shown to be an efficacious and safe immunosuppressant in phase IIb and phase III trials in renal transplant recipients and in plaque psoriasis patients. In clinical trials, Voclosporin added to standard-of-care induction therapy for lupus nephritis increases complete renal remission (CRR) rates, but higher rates of adverse events including death were observed.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/12/1085
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
||
|
WHO-ATC |
L04AD03
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
||
|
NCI_THESAURUS |
C574
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
||
|
WHO-VATC |
QL04AD03
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
||
|
FDA ORPHAN DRUG |
227806
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
M11494
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | Merck Index | ||
|
SUB31127
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | |||
|
515814-01-4
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | |||
|
C152902
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | |||
|
VOCLOSPORIN
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | |||
|
8889
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | |||
|
CHEMBL2218919
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY | |||
|
6918486
Created by
admin on Mon Oct 21 20:58:17 UTC 2019 , Edited by admin on Mon Oct 21 20:58:17 UTC 2019
|
PRIMARY |
ACTIVE MOIETY